Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Altaris Holding Ltd
Acquired Company
Simulations Plus
New York
LancasterHealth CareVenture CapitalDescription
Altaris, LLC has announced its plan to acquire Simulations Plus, Inc. for approximately $375 million in an all-cash deal. Stockholders of Simulations Plus will receive $18.50 per share, which represents a 26% premium. The acquisition is poised to accelerate Simulations Plus' growth, especially when combined with Chemical Computing Group. The transaction is expected to close in the fourth quarter of 2026.
Fundz sees it the moment Altaris Holding Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Simulations Plus?
Simulations Plus was acquired by Altaris Holding Ltd, based in New York. The deal was reported on June 16, 2026. Altaris Holding Ltd is a private investment firm. It focuses on acquiring and managing companies within various industries. The firm seeks to create long-term value through strategic management decisions. Altaris Holding Ltd is privately held and operates in Health Care.
When did Altaris Holding Ltd acquire Simulations Plus?
Altaris Holding Ltd's acquisition of Simulations Plus was reported on June 16, 2026. Altaris, LLC has announced its plan to acquire Simulations Plus, Inc. for approximately $375 million in an all-cash deal. Stockholders of Simulations Plus will receive $18.50 per share, which represents a 26% premium. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Simulations Plus do?
Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. It is publicly traded (SLP), and is based in Lancaster.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.